RGC
Regencell Bioscience Holdings Ltd
6.30$
+1.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.0% | +2.9% | -0.4% | -2.5% | +6.7% | -1.3% | +1.5% | -5.5% | -6.1% | -5.6% | +22.4% | -6.1% | +3.7% | +0.5% | +7.5% | -100.0% | +111.3% | -33.8% | +5,197.6% | -30.0% | -33.1% | -31.8% | |
| – | -3.3% | -14.6% | -18.4% | -8.0% | +117.8% | -48.0% | +57.1% | -19.2% | +16.5% | -36.1% | +80.4% | -26.6% | +28.4% | +2.0% | +3.7% | -99.9% | +59.0% | -82.7% | +24,499.6% | -29.3% | -30.2% | -39.6% | |
| – | +4.3% | -15.6% | -19.3% | -17.3% | +168.5% | -60.9% | +93.0% | -37.4% | +23.2% | -56.7% | +156.5% | -47.6% | +49.3% | +12.2% | -7.2% | -99.9% | +59.0% | -84.6% | +10,700.7% | -75.6% | +89.2% | -18.3% | |
| – | +4.3% | -15.6% | -19.3% | -17.3% | +168.5% | -60.9% | +93.0% | -35.6% | +19.7% | -56.7% | +162.9% | -47.6% | +45.5% | +12.2% | -7.2% | -99.9% | +59.0% | -84.6% | +27,532.0% | -29.6% | -31.2% | -38.5% | |
| – | – | – | – | – | – | – | – | – | – | +4.5% | +24.1% | – | – | +1.3% | +18.6% | – | – | – | +271.1% | +104.9% | +170.2% | – | |
| – | +0.0% | +16.7% | +0.0% | +14.3% | +0.0% | +0.0% | +53.8% | +19.5% | +0.7% | +20.3% | +6.7% | -6.3% | +25.8% | -6.7% | +9.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -24.4% | +1,683.4% | – | – | – | |
| – | -13.2% | +8.1% | +4.7% | -4.0% | -15.4% | -1.7% | +0.4% | +0.0% | +0.0% | +49.8% | +19.6% | +0.0% | +2.6% | -0.5% | +5.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -22.0% | +89.7% | -6.3% | +33.7% | +107.6% | -6.6% | -6.9% | -8.4% | -5.2% | – | – | – | – | – | – | – | |
| – | +61.5% | +47.7% | +1.2% | -0.5% | +10.6% | +3.2% | +1.5% | +3.4% | -2.4% | -0.2% | +17.6% | +0.5% | +2.2% | -0.7% | +6.1% | -99.9% | +52.0% | +37.1% | -78.4% | -32.6% | -65.3% | +307.9% | |
| – | +35.5% | +56.3% | +7.6% | -19.8% | -5.2% | -30.6% | +8.3% | +18.3% | -14.6% | -3.3% | +30.7% | -5.8% | +15.6% | -7.5% | +10.1% | -99.6% | +52.0% | +37.1% | -86.7% | +5.0% | -68.1% | +242.8% | |
| – | – | +19.1% | +21.4% | -23.5% | – | – | -77.8% | +460.2% | -78.5% | +6.8% | +35.5% | -10.7% | +3.0% | -6.9% | +4.3% | -92.2% | +47.5% | +19.9% | -88.8% | +6.6% | -86.4% | +423.0% | |
| – | +26.0% | -6.2% | -0.5% | -7.2% | +8.9% | -11.5% | +22.5% | -18.2% | +7.5% | -10.0% | +8.4% | -2.6% | +38.6% | -15.2% | +19.2% | – | – | – | – | – | – | – | |
| – | -37.4% | -91.1% | -56.3% | -167.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -29.5% | -31.7% | -40.9% | |
| – | -13.5% | -64.1% | +91.3% | -31.8% | +40.0% | -42.9% | +95.8% | -80.0% | +67.0% | -91.1% | +5,028.6% | -32.6% | +32.6% | +50.3% | -26.5% | -102.6% | – | – | – | – | – | – | |
| – | -3.9% | +4.8% | -97.3% | -67.8% | +340.8% | -79.9% | +13,195.9% | +0.3% | -97.4% | +3,710.7% | +0.5% | +0.4% | +0.1% | +0.2% | +0.1% | -91.9% | +0.0% | +0.0% | +2.9% | +0.0% | +0.0% | +0.0% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.